rs35163651
|
NFYA;OARD1
|
White Blood Cell Count procedure
|
GT |
0.700 |
GeneticVariation |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
rs6912013
|
NFYA;OARD1
|
Leukemia, Myelocytic, Acute
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
rs7760860
|
NFYA;OARD1
|
Leukemia, Myelocytic, Acute
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
rs9296355
|
NFYA;OARD1
|
Leukemia, Myelocytic, Acute
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
rs9296355
|
NFYA;OARD1
|
Leukemia, Myelocytic, Acute
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
rs2268188
|
NFYA;OARD1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
Haplotype analysis showed that SNPs rs2268188, rs6918969, rs28869187, and rs35105472 formed a haplotype block, and haplotype TTAC was protective against T2DM (OR = 0.76, 95% CI = 0.33-0.82, <i>P</i> = 0.004), while haplotype GCCG was associated with an elevated susceptibility to T2DM (OR = 2.33, 95% CI = 1.43-3.57, <i>P</i> = 0.001).
|
31205951 |
2019 |
rs28869187
|
NFYA;OARD1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
Of the five tagSNPs, we found that three SNPs (rs2268188, rs6918969, and rs28869187) exhibited nominal significant differences in allelic or genotypic frequency between patients with T2DM and healthy individuals.
|
31205951 |
2019 |
rs35105472
|
NFYA;OARD1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
Haplotype analysis showed that SNPs rs2268188, rs6918969, rs28869187, and rs35105472 formed a haplotype block, and haplotype TTAC was protective against T2DM (OR = 0.76, 95% CI = 0.33-0.82, <i>P</i> = 0.004), while haplotype GCCG was associated with an elevated susceptibility to T2DM (OR = 2.33, 95% CI = 1.43-3.57, <i>P</i> = 0.001).
|
31205951 |
2019 |
rs6918969
|
NFYA;OARD1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
The minor alleles G, C, and C at rs2268188, rs6918969</span>, and rs28869187, respectively, conferred a higher T2DM risk under a dominant genetic model, and the carriers of these risk alleles (either homozygotes of the minor allele or heterozygotes) had statistically higher levels of fasting plasma glucose, cholesterol, and triglycerides.
|
31205951 |
2019 |